Cost-effectiveness analysis of routine pediatric vaccination of 15-valent pneumococcal conjugate vaccine in South Korea

Pneumococcal disease poses a substantial clinical and economic burden, especially among children under 5 years old. The 13-valent pneumococcal conjugate vaccine (PCV13) was first introduced in South Korea’s Childhood Immunization Program in 2014. In October 2023, the Ministry of Food and Drug Safety...

Full description

Bibliographic Details

Published in:	Human Vaccines & Immunotherapeutics
Main Authors:	Young June Choe, Yunjin Jeon, Jihyun Park, Hyesun Kim, Gyongseon Yang, Salini Mohanty, Lefteris Floros, Min Huang, Nitika Chhabra, Shalini Kumari, Jasmeet Singh, Isaya Sukarom
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2025-12-01
Subjects:	Invasive pneumococcal disease Streptococcus pneumoniae bacteremic pneumococcal pneumonia acute otitis media
Online Access:	https://www.tandfonline.com/doi/10.1080/21645515.2025.2515650